Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
3613.HK Stock Price Chart
Explore Beijing Tong Ren Tang Chinese Medicine Company Limited interactive price chart. Choose custom timeframes to analyze 3613.HK price movements and trends.
3613.HK Company Profile
Discover essential business fundamentals and corporate details for Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
7 May 2013
Employees
782.00
Website
https://www.tongrentangcm.comCEO
Wang Chi
Description
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates 23 retail outlets in Hong Kong and 46 retail outlets in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. The company was founded in 1669 and is based in Wan Chai, Hong Kong.
3613.HK Financial Timeline
Browse a chronological timeline of Beijing Tong Ren Tang Chinese Medicine Company Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 22 Aug 2025
EPS came in at $0.28 , while revenue for the quarter reached $761.74M .
Earnings released on 6 Jun 2025
Dividend declared on 5 Jun 2025
A dividend of $0.35 per share was announced, adjusted to $0.35. The dividend was paid on 18 Jun 2025.
Earnings released on 28 Mar 2025
EPS came in at $0.17 , while revenue for the quarter reached $473.56M .
Earnings released on 31 Dec 2024
EPS came in at $0.17 , while revenue for the quarter reached $473.56M .
Earnings released on 30 Aug 2024
EPS came in at $0.13 , while revenue for the quarter reached $332.26M .
Dividend declared on 12 Jun 2024
A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 24 Jun 2024.
Earnings released on 7 Jun 2024
EPS came in at $0.13 , while revenue for the quarter reached $332.26M .
Earnings released on 15 Mar 2024
EPS came in at $0.16 , while revenue for the quarter reached $356.07M , missing expectations by -79.48%.
Earnings released on 27 Dec 2023
EPS came in at $0.16 , while revenue for the quarter reached $356.07M .
Earnings released on 10 Aug 2023
EPS came in at $0.16 , while revenue for the quarter reached $406.40M .
Earnings released on 30 Jun 2023
EPS came in at $0.16 , while revenue for the quarter reached $406.40M .
Dividend declared on 10 May 2023
A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 31 May 2023.
Earnings released on 13 Mar 2023
EPS came in at $0.26 , while revenue for the quarter reached $552.37M , missing expectations by -72.88%.
Earnings released on 31 Dec 2022
EPS came in at $0.26 , while revenue for the quarter reached $552.37M .
Dividend declared on 6 Oct 2022
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 21 Oct 2022.
Earnings released on 30 Jun 2022
EPS came in at $0.26 , while revenue for the quarter reached $626.36M .
Dividend declared on 14 Jun 2022
A dividend of $0.28 per share was announced, adjusted to $0.28. The dividend was paid on 30 Jun 2022.
Earnings released on 31 Mar 2022
EPS came in at $0.13 , while revenue for the quarter reached $313.18M .
Earnings released on 31 Dec 2021
EPS came in at $0.41 , while revenue for the quarter reached $852.13M .
Earnings released on 30 Sept 2021
EPS came in at $0.20 , while revenue for the quarter reached $426.06M .
Earnings released on 30 Jun 2021
EPS came in at $0.32 , while revenue for the quarter reached $704.03M .
Dividend declared on 1 Jun 2021
A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 30 Jun 2021.
Earnings released on 31 Mar 2021
EPS came in at $0.16 , while revenue for the quarter reached $352.02M .
Earnings released on 31 Dec 2020
EPS came in at $0.38 , while revenue for the quarter reached $747.92M .
Earnings released on 30 Sept 2020
EPS came in at $0.19 , while revenue for the quarter reached $373.96M .
3613.HK Stock Performance
Access detailed 3613.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.